Kristina Imeen Ringe1, Christian von Falck1, Hans-Juergen Raatschen1, Frank Wacker1, and Jan Bernd Hinrichs1
purpose of our present study was to evaluate the incidence of TSM at gadoxetate
disodium-enhanced MRI using different contrast application protocols, i.e. by
variation of contrast injection rate, dose and supplemental nasal oxygen
application. In addition to quantitative SNR measurements, motion artifacts and
arterial phase image quality were compared. The overall incidence of TSM in our
study population was 11.5%, and neither variation of contrast application
parameter was able to significantly reduce the occurrence of these artifacts.